SG Americas Securities’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Sell |
5,345
-1,150,442
| -100% | -$61.3M | ﹤0.01% | 1838 |
|
|
2025
Q1 | $46.8M | Buy |
1,155,787
+557,794
| +93% | +$22.6M | 0.15% | 90 |
|
|
2024
Q4 | $16.6M | Buy |
597,993
+583,486
| +4,022% | +$16.2M | 0.07% | 136 |
|
|
2024
Q3 | $416K | Sell |
14,507
-10
| -0.1% | -$287 | ﹤0.01% | 1640 |
|
|
2024
Q2 | $341K | Buy |
14,517
+9,532
| +191% | +$224K | ﹤0.01% | 1715 |
|
|
2024
Q1 | $126K | Sell |
4,985
-2,503
| -33% | -$63.3K | ﹤0.01% | 2100 |
|
|
2023
Q4 | $175K | Sell |
7,488
-11,646
| -61% | -$272K | ﹤0.01% | 2077 |
|
|
2023
Q3 | $968K | Buy |
19,134
+11,148
| +140% | +$564K | 0.01% | 1199 |
|
|
2023
Q2 | $373K | Buy |
7,986
+1,498
| +23% | +$70K | ﹤0.01% | 1342 |
|
|
2023
Q1 | $248K | Buy |
6,488
+637
| +11% | +$24.3K | ﹤0.01% | 2066 |
|
|
2022
Q4 | $321K | Sell |
5,851
-10,250
| -64% | -$562K | ﹤0.01% | 1672 |
|
|
2022
Q3 | $548K | Sell |
16,101
-5,314
| -25% | -$181K | 0.01% | 1291 |
|
|
2022
Q2 | $202K | Buy |
+21,415
| New | +$202K | ﹤0.01% | 2429 |
|
|
2021
Q4 | – | Sell |
-52,255
| Closed | -$1.17M | – | 2936 |
|
|
2021
Q3 | $1.17M | Buy |
52,255
+28,742
| +122% | +$642K | 0.01% | 1618 |
|
|
2021
Q2 | $583K | Sell |
23,513
-451
| -2% | -$11.2K | ﹤0.01% | 1693 |
|
|
2021
Q1 | $695K | Buy |
+23,964
| New | +$695K | ﹤0.01% | 1618 |
|
|
2020
Q3 | – | Sell |
-6,087
| Closed | -$152K | – | 2143 |
|
|
2020
Q2 | $152K | Buy |
+6,087
| New | +$152K | ﹤0.01% | 2669 |
|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$192K | – | 2441 |
|
|
2019
Q2 | $192K | Buy |
+10,000
| New | +$192K | ﹤0.01% | 2094 |
|